Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Timing is everything: Novel Combinatorial Approaches to Overcome the Immunosuppression in Prostate Cancer
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
Encouraging Results from Phase 2a COVID-19 Clinical Trial with the Oral Direct-Acting Antiviral MolnupiravirJuly 7, 2021
Platelet-activating anti-PF4 antibodies linked to the vaccine-induced immune thrombotic thrombocytopeniaApril 19, 2021
Identification of GM-SCF as possible distinctive blood marker predicting severe COVID-19March 23, 2021
Bamlanivimab (an Investigational Monoclonal Antibody): FDA Authorizes its Emergency Use for the Treatment of Mild to Moderate COVID-19November 11, 2020
High Affinity Human Antibody Component Identified as a Potential Targeted SARS-Cov-2 TherapyNovember 3, 2020
NIH begins the first large randomized controlled trial of the combination of interferon beta-1a and remdesivir for treating COVID-19August 13, 2020
Remdesivir: The European Commission Approves this Drug for the Treatment of Severe Cases of COVID-19July 4, 2020
